Quantcast
Last updated on April 24, 2014 at 0:05 EDT

Latest Thyroid neoplasm Stories

2012-07-17 06:25:07

SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, Mass., July 17, 2012 /PRNewswire/ -- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the publication of new data suggesting that routine clinical use of Veracyte's Afirma® Gene Expression Classifier helps to significantly reduce the number of surgeries performed on patients whose thyroid nodule cytology results...

2012-06-25 23:21:50

Penn Medicine editorial suggests 25,000 unnecessary surgeries can be avoided A new test can be used to identify low-risk thyroid nodules, reducing unnecessary surgeries for people with thyroid nodules that have indeterminate results after biopsy. The results of the multi-center trial, which includes researchers from the Perelman School of Medicine at the University of Pennsylvania, appear online in the New England Journal of Medicine. Ultrasound-guided fine-needle aspiration biopsies...

2012-06-21 02:14:41

A molecule widely believed to fight many forms of cancer actually helps deadly thyroid tumors grow, and cancer therapies now being tested in humans might boost the activity of this newly revealed bad guy, researchers at Mayo Clinic in Florida say. Their findings are published online this month in the Journal of Cell Science. The study found that in anaplastic thyroid cancer, the Forkhead transcription factor, FOXO3a, is not the helpful tumor suppressor everyone thought it was, but,...

2012-06-11 20:35:05

Study finds that the majority of patients with thyroid cancer, except for those in the most advanced stage, continue to have the same chance of survival as those who are disease-free Research presented at the Society of Nuclear Medicine's 59th Annual Meeting reveals that patients with differentiated thyroid cancer live as long as people in perfect health, unless they are in the minority and have reached the most advanced stages of disease. Survival did not vary based on age, sex, or even...

2012-06-01 10:22:01

MADISON, N.J., June 1, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced a new molecular test panel designed to help physicians determine if a thyroid gland is cancerous and requires surgical removal. The test is believed to be the most comprehensive panel clinically available to identify mutations associated with four gene markers indicated by the American Thyroid Association for the clinical...

2012-05-22 08:37:40

A review of medical records of patients treated at an academic tertiary care center suggests that obese patients present to their physicians with more advanced stage and more aggressive forms of papillary thyroid cancer (PTC), according to a report published Online First by Archives of Surgery, a JAMA Network publication. Thyroid cancer is on the rise on the United States and most of the increase is due to PTC, although the authors write that it is debatable whether the increase is caused...

2012-05-03 18:43:21

The use of single positron emission computed tomography (SPECT)/computed tomography (CT) has been reported to change clinical management in a significant number of thyroid cancer patients according to research presented in the May issue of The Journal of Nuclear Medicine. Information obtained from these scans not only helps determine the need for radioiodine therapy or alterative options, but also impacts the long-term follow-up strategy. “In this article I aimed to highlight the...

2012-04-17 06:25:18

AUSTIN, Texas, April 17, 2012 /PRNewswire/ -- HCB Health, one of the top 25 independent healthcare communications agencies in the U.S., has been selected by the Thyroid, Head and Neck Cancer (THANC) Foundation to create a specialized website for head and neck cancer patients and their families. THANC is the nation's largest private funder of research for these types of cancer. The HCB assignment centers on developing a website that will serve as a resource for patients, caregivers and...

2012-04-05 02:24:15

SOUTH SAN FRANCISCO, Calif., April 5, 2012 /PRNewswire/ -- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced the appointment of Richard T. Kloos, M.D., as senior medical director. In this role, Dr. Kloos will educate the endocrinology community about the company's first product, the Afirma® Thyroid FNA Analysis, and will lead all thyroid product medical efforts. Dr. Kloos was previously professor in the divisions of...

2012-03-30 07:42:16

New study challenges assumption that thyroidectomy is a low-risk operation for older patients Elderly patients who undergo thyroid surgery are at a much higher risk than their younger counterparts for serious cardiac, pulmonary and infectious complications, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). The study findings challenge long-held beliefs that thyroidectomy carries the same risk level of...